Development Vaccine

Group A Streptococcus vaccines target Strep A, which causes pharyngitis, skin infections, rheumatic ...

Universal influenza vaccine research aims to develop a vaccine that provides protection against all ...

HIV vaccine research began in 1987 and has been one of the most challenging fields in vaccinology. H...

New tuberculosis vaccines are urgently needed as BCG provides variable protection. M72 AS01E, develo...

Norovirus vaccines target the leading cause of acute gastroenteritis. Norovirus causes approximately...

Cytomegalovirus CMV vaccine development has been ongoing for decades. CMV is the most common congeni...

Group B Streptococcus GBS vaccine targets the leading cause of sepsis and meningitis in newborns. GB...

West Nile virus WNV vaccine development began after WNV appeared in North America in 1999. WNV sprea...

Zika vaccine development accelerated during the 2015 to 2016 Zika epidemic in the Americas. Zika vir...

Nipah virus vaccine development is motivated by case fatality rates estimated at 40 to 75 percent an...

Lassa fever vaccine development targets a viral hemorrhagic fever endemic in West Africa. Lassa viru...

Middle East Respiratory Syndrome MERS vaccine development began after MERS was identified in Saudi A...

SARS vaccine development began during the 2003 SARS epidemic. SARS emerged in China in November 2002...

VLA15, developed by Valneva and Pfizer, is a Lyme disease vaccine candidate targeting Borrelia burgd...

Acinetobacter baumannii vaccine development targets a multidrug resistant bacterium that causes infe...

Candida auris vaccine development targets a multidrug resistant fungus first identified in 2009. Can...

Gonorrhea vaccine development has been challenging due to the antigenic variability of Neisseria gon...

Uropathogenic E coli vaccine development targets the leading cause of urinary tract infections UTIs....

Staphylococcus aureus vaccine development has been notoriously difficult. S aureus causes skin infec...